Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Journal of Hypertension|August 18, 2017
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study reportRaffaella Dell'Oro, Edoardo Gronda, Gino Seravalle, et al.Giornale Italiano Di Cardiologia (2006)|June 17, 2010
[Gender differences of at risk patients with overt heart failure in the real world of general practice. Data from the GIPSI (Gestione Integrata Progetto Scompenso in Italia) registry]Edoardo Gronda, Alberto Aronica, Marco Visconti, et al.Pacing and Clinical Electrophysiology : PACE|April 12, 2003
Is the outcome of cardiac resynchronization therapy related to the underlying etiology?Maurizio Gasparini, Massimo Mantica, Paola Galimberti, et al.International Journal of Cardiology|June 9, 2025
Heart failure and co-morbidities confer a negative prognosis in COVID-19 infectionAntonio E Pontiroli, Giuseppe Ambrosio, Olivia Leoni, et al.Pacing and Clinical Electrophysiology : PACE|February 17, 2007
Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS?Maurizio Gasparini, François Regoli, Paola Galimberti, et al.British Journal of Haematology|June 17, 2004
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantationMassimo Cugno, Daniela Mari, Pier Luigi Meroni, et al.Journal of Hypertension|July 2, 2015
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fractionEdoardo Gronda, Gino Seravalle, Fosca Quarti Trevano, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 7, 2009
Current state of knowledge and experts' perspective on the subcutaneous implantable cardioverter-defibrillatorMassimo Santini, Riccardo Cappato, Dietrich Andresen, et al.Pacing and Clinical Electrophysiology : PACE|April 12, 2003
Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy?Maurizio Gasparini, Massimo Mantica, Paola Galimberti, et al.Pacing and Clinical Electrophysiology : PACE|October 28, 2008
Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapyMaurizio Mangiavacchi, Maurizio Gasparini, Stefano Genovese, et al.Pageof 7